PMID: 8583003Jul 1, 1995Paper

US public policy on embryo research: two steps forward, one large step back

Human Reproduction
J C Fletcher

Abstract

This article gives an overview of the final report of the National Institutes of Health (NIH) Embryo Research Panel, which was issued on September 27, 1994 (NIH, 1994). The report was endorsed unanimously by the Advisory Committee to the Director of the NIH, Harold Varmus, on December 2, 1994. A few hours later, President Clinton (Marshall, 1994) issued a statement announcing that he did 'not believe that federal funds should be used to support the creation of human embryos for research purposes', and that he had directed the NIH not to support such research, which was one of the areas of research recommended for Federal funding by the Panel. At present, Dr Varmus is in the process of considering the Panel's report and shaping guidelines to govern the review and conduct of human embryo research. Any guidelines will be published in the Federal Register for comment at a later date. As a result of changes brought about by Congress in 1993, Federal support for research focused on in-vitro fertilization (IVF) could go forward. This represented the first advance in research freedom in the Federal sector to study approaches to IVF. It will involve the NIH in peer review and scientific activities regarding IVF. Assuming that Dr Varmus ...Continue Reading

Citations

Jan 31, 2013·Medicine, Health Care, and Philosophy·Thomas V Cunningham
Jun 1, 2001·The Annals of Thoracic Surgery·R M El OakleyM H Yacoub

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.